Cite
HARVARD Citation
Doorduijn, J. et al. (2020). Bortezomib maintenance after R‐CHOP, cytarabine and autologous stem cell transplantation in newly diagnosed patients with mantle cell lymphoma, results of a randomised phase II HOVON trial. British journal of haematology. pp. 385-393. [Online].